Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Cappabianca

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|September 23, 2022
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma CellsLucia Cappabianca, Michela Sebastiano, Marianna Ruggieri, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 24, 2019
A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic targetLucia Cappabianca, Stefano Guadagni, Rita Maccarone, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 20, 2018
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIIIAntonietta Rosella Farina, Lucia Cappabianca, Pierdomenico Ruggeri, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 7, 2019
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastomaLucia Cappabianca, Antonietta Rosella Farina, Lucia Di Marcotullio, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 24, 2002
All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma CellsAntonietta R Farina, Maria-Paola Masciulli, Antonella Tacconelli, et al.
Cancers|February 13, 2025
A TaqMan-Based qRT-PCR Assay for Accurate Evaluation of the Oncogenic <i>TrkAIII</i> Splice Variant in Tumor cDNAsMaddalena Sbaffone, Antonietta Rosella Farina, Ilaria Martelli, et al.
Biomed Research International|July 11, 2013
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotypeAntonietta R Farina, Natalia Di Ianni, Lucia Cappabianca, et al.
FEBS Letters|June 9, 2012
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domainAntonietta R Farina, Lucia Cappabianca, Natalia Di Ianni, et al.
Plos One|April 17, 2014
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotypePierdomenico Ruggeri, Antonietta R Farina, Natalia Di Ianni, et al.
International Journal of Molecular Sciences|May 25, 2024
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma CellsLucia Cappabianca, Marianna Ruggieri, Michela Sebastiano, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|September 23, 2022
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma CellsLucia Cappabianca, Michela Sebastiano, Marianna Ruggieri, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 24, 2019
A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic targetLucia Cappabianca, Stefano Guadagni, Rita Maccarone, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 20, 2018
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIIIAntonietta Rosella Farina, Lucia Cappabianca, Pierdomenico Ruggeri, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 7, 2019
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastomaLucia Cappabianca, Antonietta Rosella Farina, Lucia Di Marcotullio, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 24, 2002
All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma CellsAntonietta R Farina, Maria-Paola Masciulli, Antonella Tacconelli, et al.
Cancers|February 13, 2025
A TaqMan-Based qRT-PCR Assay for Accurate Evaluation of the Oncogenic <i>TrkAIII</i> Splice Variant in Tumor cDNAsMaddalena Sbaffone, Antonietta Rosella Farina, Ilaria Martelli, et al.
Biomed Research International|July 11, 2013
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotypeAntonietta R Farina, Natalia Di Ianni, Lucia Cappabianca, et al.
FEBS Letters|June 9, 2012
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domainAntonietta R Farina, Lucia Cappabianca, Natalia Di Ianni, et al.
Plos One|April 17, 2014
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotypePierdomenico Ruggeri, Antonietta R Farina, Natalia Di Ianni, et al.
International Journal of Molecular Sciences|May 25, 2024
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma CellsLucia Cappabianca, Marianna Ruggieri, Michela Sebastiano, et al.
Pageof 3